Progenics Pharmaceuticals Announces Presentation at RSNA

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Progenics Pharmaceuticals Announces Presentation at RSNA Annual Meeting

TARRYTOWN, N.Y., Dec. 2, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ) today announced that data from the Phase 2 trial of its PSMA imaging agent candidate, 1404, will be presented at the upcoming Radiological Society of North America Annual Meeting, taking place in Chicago from November 30 – December 5, 2014.

The details for the oral presentation are as follows:

Date and Time: December 4 th at 10:40 a.m.
Title: A Phase 2 Study of 99mTc-Trofolastat Chloride SPECT/CT to Identify and Localize Prostate Cancer in Patients Undergoing Radical Prostatectomy and Extended Pelvic Lymph Node Dissection Compared to Histopathology
Abstract Number: SSQ12-02
Session: Molecular Imaging (Prostate Cancer/Bone Metastases)
Presenter: Kevin Slawin, M.D., Director, Vanguard Urologic Institute and the Texas Prostate Center

About 1404, an Imaging Compound Targeting Prostate Specific Membrane Antigen

1404 is a developmental stage radiopharmaceutical imaging agent designed to highlight the expression of distinct proteins by diseased cells. The image created provides the opportunity to "visualize cancer," potentially allowing for improved detection and staging, more precise biopsies, and a targeted treatment plan including active surveillance as a disease management tool.

About Prostate Cancer

Prostate cancer is the second most common form of cancer affecting men in the United States: an estimated one in six will be diagnosed with prostate cancer in his lifetime. The American Cancer Society estimates that approximately 240,000 new cases of prostate cancer will be diagnosed and about 30,000 men will die of the disease this year, and that approximately two million men in the U.S. currently count themselves among prostate cancer survivors.

About Progenics

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics' first-in-class PSMA-targeted technology platform for prostate cancer includes an antibody drug conjugate therapeutic in a two-cohort phase 2 clinical trial and a small molecule imaging agent that has completed patient dosing in a phase 2 trial. Among other assets in its pipeline of targeted radiotherapy and molecular imaging compounds is Azedra ™ , an ultra-orphan radiotherapy candidate also in a phase 2 study under an SPA. Progenics' first commercial product, Relistor ® (methylnaltrexone bromide) for opioid-induced constipation, is partnered with and marketed by Salix Pharmaceuticals, Inc. For additional information, please visit www.progenics.com .        

This press release may contain projections and other forward-looking statements regarding future events. Such statements are predictions only, and are subject to risks and uncertainties that could cause actual events or results to differ materially. These risks and uncertainties include, among others, the cost, timing and results of clinical trials and other development activities; the unpredictability of the duration and results of regulatory review of New Drug Applications and Investigational NDAs; market acceptance for approved products; generic and other competition; the possible impairment of, inability to obtain and costs of obtaining intellectual property rights; and possible safety or efficacy concerns, general business, financial and accounting matters, litigation and other risks. More information concerning Progenics and such risks and uncertainties is available on its website, and in its press releases and reports it files with the U.S. Securities and Exchange Commission. Progenics is providing the information in this press release as of its date and does not undertake any obligation to update or revise it, whether as a result of new information, future events or circumstances or otherwise.

Additional information concerning Progenics and its business may be available in press releases or other public announcements and public filings made after this release. For more information, please visit www.progenics.com . Please follow us on LinkedIn ® .

Information on or accessed through our website or social media sites is not included in the company's SEC filings.

(PGNX-F)

Editors Note :

For more information about Relistor, please visit www.relistor.com .

Melissa Downs Investor Relations (914) 789-2801

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Chicken Production Rises Amid Meat Market Shifts

Updated Category News Views 187

Protein Markets Scramble: Chicken Production Climbs Here’s a tasty tidbit that might just have investors reeling: the USDA says chicken production will be cruising on the up, whereas beef is taking a bit of a backseat. Yep, the big birds are flying higher, and the cows, well, they're just mooing a little softer. And what's that mean for big players like Tyson...

Continue Reading
LA Auto Show 2026: Thrills, Games, and Cars Galore

Updated Category News Views 53

A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 221

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 206

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 162

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 117

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 215

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 163

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading

Top 5 Most Recently Viewed Articles

Essential Guidance to Avoid Contractor Fraud After Disasters

Updated Category News Views 249

Essential Guidance for Consumers: Preventing Contractor Fraud In times of devastating natural disasters, such as those caused by wildfires, consumers often find themselves in vulnerable positions. High winds and dry conditions can lead to situations where homes, businesses, and even schools suffer severe damage. It’s in these challenging times that the threat of...

Continue Reading
Stefan Vinberg: A Visionary Leader in Sustainable Real Estate

Updated Category News Views 60

Stefan Vinberg Achieves Dual Recognition at Prestigious Awards Stefan Vinberg, the respected CEO of Insig AB, has recently received outstanding recognition by winning two significant accolades at the Business Worldwide Magazine CEO Awards. These notable honors are the 'Sustainable Real Estate Leadership Award' and 'Growth Strategy CEO of the Year - Sweden'. This...

Continue Reading
SIME Diagnostics Unveils Breakthrough in Neonatal Lung Testing

Updated Category News Views 344

Introduction to AI in Neonatal Medicine SIME Diagnostics is transforming neonatal care with its innovative approach to evaluating lung maturity in preterm infants. This UK-based medical technology company has recently completed a significant clinical study aimed at addressing respiratory challenges faced by late-preterm newborns. The findings promise not only to enhance...

Continue Reading
Baxter Intl's Q4 Results: Key Takeaways and Insights

Updated Category News Views 164

Understanding Baxter Intl's Q4 Earnings The recent earnings report from Baxter Intl (NYSE: BAX) provides crucial insights for investors and analysts alike. In the fourth quarter, the company revealed some significant insights into its financial health and market performance, prompting a closer examination of what this means for shareholders. Earnings Performance Overview...

Continue Reading
Morgan Stanley Sheds Light on UK Investment Trends

Updated Category News Views 99

Insights on UK Investment Intentions From Morgan Stanley Recently, UK assets have captured significant attention, prompting Morgan Stanley (NYSE: MS) to conduct a survey aimed at understanding investors' views, intentions, and positions regarding these assets. This survey highlights the current sentiment surrounding investments in the UK amid uncertain market conditions....

Continue Reading